Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 3Mastectomy 1Cystic Fibrosis 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Mastectomy, Simple × Clear all
NCT04585074 2025-05-15

MARRES

Severance Hospital

Active not recruiting
2,000 enrolled
Breast

Breast Neoplasms, Cystic Fibrosis

NCT04270136 2023-09-13

AMASTEC

Centre Hospitalier Universitaire, Amiens

Phase NA Completed
1 enrolled
Breast

Breast Neoplasms

NCT03181139 2017-06-08

ERAS_Breast

University of California, San Francisco

Completed
386 enrolled
Breast

Mastectomy

NCT01055678 2012-12-17

To Evaluate the Characteristics of a Breast Cancer

Duke University

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡